QIAGEN announced plans to release a new fully automated workflow and an AI-powered risk stratification tool to improve QuantiFERON latent tuberculosis (TB) testing. The new workflow will automate the entire process from sample to insight, while the AI tool will help to identify individuals at high risk of developing active TB.
The fully automated workflow is designed to streamline the QuantiFERON TB Gold Plus assay, reducing hands-on time and minimizing the risk of human error. The AI-enabled risk stratification tool will analyze patient data to predict the likelihood of TB activation, allowing for more targeted interventions and preventative care. QIAGEN expects these innovations to enhance the efficiency and accuracy of latent TB testing, ultimately contributing to better patient outcomes and public health.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 7, 2026
發佈留言